# Pharmacological Effects of Pascoflair® on Brain Activity in Patients Suffering From Test Anxiety

> **NCT05049447** · PHASE4 · COMPLETED · sponsor: **Pascoe Pharmazeutische Praeparate GmbH** · enrollment: 40 (actual)

## Conditions studied

- Stress
- Brain Activity
- Passiflora Incarnata
- Test Anxiety

## Interventions

- **DRUG:** Pascoflair
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT05049447
- **Lead sponsor:** Pascoe Pharmazeutische Praeparate GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-05
- **Primary completion:** 2015-08
- **Final completion:** 2015-08
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2021-09-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05049447

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05049447, "Pharmacological Effects of Pascoflair® on Brain Activity in Patients Suffering From Test Anxiety". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05049447. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*